BRCA1 and breast neoplasm: Liu, et al. also found that the active TGFβ signaling exhibited resistance to the DNA-damaging agent doxorubicin in some breast tumors [29], and TGFβ induces a DNA-repair deficiency through downregulating DNA-repair genes, such as ATM, and BRCA1 [30].